Holen Sie sich die Stockscreener-App
540.03
0.62%
-3.37
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.23%
783.30
|
781.50 | 790.20 | 799.50 | 798.60 |
| Cost Of Revenue |
25.41%
99.50
|
133.40 | 103.40 | 100.90 | 87.60 |
| Gross Profit |
5.51%
683.80
|
648.10 | 686.80 | 698.60 | 711.00 |
Selling, General, and Administrative
|
12.28%
206.70
|
184.10 | 190.60 | 182.60 | - |
| Costs And Expenses |
0.70%
452.50
|
455.70 | 433.50 | 411.00 | 434.10 |
| Operating Income/Loss |
1.53%
330.80
|
325.80 | 356.70 | 388.50 | 364.50 |
| Nonoperating Income/Loss |
658.67%
41.90
|
-7.50 | 87.30 | 49.50 | 43.90 |
| Income/Loss From Continuing Operations Before Tax |
17.09%
372.70
|
318.30 | 444.00 | 438.00 | 408.40 |
| Income Tax Expense/Benefit, Deferred |
0.77%
25.70
|
25.90 | - | - | - |
| Income Tax Expense/Benefit |
8.53%
39.70
|
43.40 | 79.70 | 99.30 | 98.90 |
| Net Income/Loss |
21.13%
333.00
|
274.90 | 364.30 | 338.70 | 309.50 |
| Basic Average Shares |
2.07%
42.60
|
43.50 | - | 43.80 | 45.10 |
| Diluted Average Shares |
2.97%
45.80
|
47.20 | - | 47.30 | 48.30 |
| Basic Earnings Per Share |
23.73%
7.82
|
6.32 | - | 7.73 | 6.86 |
| Diluted Earnings Per Share |
24.91%
7.27
|
5.82 | - | 7.16 | 6.41 |
1.10%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):